文献速递遗传性与小管间质肾病慢性肾脏病

遗传性范可尼综合征患者的基因筛查

Genetic Screening of Patients With Inherited Fanconi Syndrome.
PubMed 文献 · Kidney Int Rep · 2026-05-05

这项回顾性研究纳入2016至2024年间接受靶向 panel 测序的20个FRTS家系(14例儿童、6例成人先证者),在13/20例(65%)先证者中检出致病变异,以GATM(n=7)最常见。结合既往病例分析,GATM变异者常表现为不完全性FRTS,肾功能进行性下降,中位肾脏生存年龄为51.9岁。

要点

  • FRTS先证者中单基因病因检出率65%,GATM变异最常见(7/20)。
  • GATM变异者常呈不完全性FRTS表型,临床谱较既往认识更广。
  • 对不完全性近端小管异常或不明原因CKD患者应考虑GATM变异检测。

核心结论

  • 超过半数原发性FRTS患者可检出单基因病因,GATM变异意外常见。
  • GATM相关FRTS为进行性小管病,存在表型变异与被低估的问题。

研究设计与样本

  • 回顾性研究,纳入20个FRTS家系(14例儿童、6例成人先证者)。
  • 2016至2024年间接受靶向panel测序,并复习既往报道病例。

主要发现

  • 13/20例先证者(65%;儿童4例、成人9例)检出致病变异。
  • 检出基因为GATM(n=7)、CLCN5(n=2)、HNF4A(n=1)、BCS1L(n=1)、CTNS(n=1)、EHHADH(n=1)。
  • 7个GATM变异中4个为全新变异,另2个为本研究组首次报道。
  • GATM变异者常表现为不完全性FRTS,肾功能进行性下降。
  • 本队列与已发表病例合并分析显示中位肾脏生存年龄为51.9岁。

临床怎么用

  • 对不完全性近端小管异常或不明原因CKD患者,应考虑GATM变异检测。
  • FRTS患者应进行基因检测以明确单基因病因并指导随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The clinical and genetic spectrum of inherited Fanconi renotubular syndrome (FRTS) remains incompletely characterized, and the role of recently recognized genes such as GATM has not been systematically assessed. METHODS: This retrospective study included 20 families with FRTS (14 pediatric and 6 adult index cases) who underwent targeted panel sequencing between 2016 and 2024. The variant spectrum and clinical characteristics were evaluated. Previously reported cases were reviewed to elucidate the phenotypic spectrum and renal prognosis in patients with GATM variants. RESULTS: Pathogenic variants were identified in 13 of 20 index cases (65%; 4 pediatric, 9 adult cases). Disease-causing genes detected included GATM (n = 7), CLCN5 (n = 2), HNF4A (n = 1), BCS1L (n = 1), CTNS (n = 1), and EHHADH (n = 1). Notably, 4 of the 7 GATM variants were completely novel, and 2 others were first reported by our group. The review, incorporating our cases, revealed that patients with GATM variants frequently exhibited incomplete FRTS, expanding the known clinical spectrum. Kidney function exhibited progressive decline, with combined analyses of our cohort and published cases indicating a median kidney survival age of 51.9 years, establishing GATM-associated FRTS as progressive tubulopathy. CONCLUSION: Over half of the patients with primary FRTS displayed detectable monogenic etiologies, with GATM variants being unexpectedly prevalent. Our findings provide new insights into the genetic and clinical spectrum of FRTS with GATM variants, highlighting its under-recognition, phenotypic variability, and progressive kidney dysfunction. GATM variants should be considered in patients with incomplete proximal tubular abnormalities or unexplained chronic kidney disease (CKD).

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Inoki Y, Sakakibara N, Yamamoto A, et al. Genetic Screening of Patients With Inherited Fanconi Syndrome. Kidney Int Rep. 2026. PMID: 42282999. doi:10.1016/j.ekir.2026.106576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。